The United States Patent Office has granted Maryland-based Curio Wellness a utility patent for its cannabis sleep aid, Good Night.
Good Night’s patented technology secures a unique, pulse-delivery system for medicinal cannabis sleep products. The ratio tablet is designed to help consumers fall asleep faster, stay asleep longer, and reduce morning grogginess by dosing in two stages: immediately and again in about three hours.
“This patent validates the revolutionary nature of the product development efforts at Curio and the novel application of our pulse-release technology,” says Edward Rudnic, PhD, chairman of Curio’s scientific board and its chief scientific officer, in a release. “This is the first of many condition-specific product patents we anticipate to issue over the coming years thanks to the continued innovation and unmatched clinical testing executed by Curio’s product innovation team.”
The proprietary pulse-release doses in two stages for sustained release and has been scientifically proven to improve sleep quality. An independent study, published in the American Journal of Endocannabinoid Medicine, found that participants woke up less frequently and spent less time awake at night. Additionally, 65% of participants reported feeling more satisfied with their sleep and feeling better rested during the day four times per week, double the rate found before the trial.
“Curio’s medical-based research methods are the foundation of all the innovative work we have accomplished thus far,” says Michael Bronfein, CEO of Curio Wellness and co-inventor, in a release. “This patent is a significant and exciting milestone for Curio and solidifies our commitment to developing cutting-edge cannabis products that enable our patients to enjoy a better quality of life.”
Curio Wellness’ patent will be in force until January 2042.
Photo caption: Good Night cannabis sleep aid
Photo credit: Curio Wellness
